Early determinants of atherosclerosis in paediatric systemic lupus erythematosus

被引:0
|
作者
Boros, C. A. [1 ,6 ,9 ]
Bradley, T. J. [2 ,9 ]
Cheung, M. M. H. [2 ,9 ]
Bargman, J. M. [5 ,7 ]
Russell, J. L. [2 ,9 ]
McCrindle, B. W. [2 ,9 ]
Adeli, K. [3 ]
Hamilton, J. [4 ,9 ]
Silverman, E. D. [1 ,6 ,8 ,9 ]
机构
[1] Hosp Sick Children, Div Rheumatol, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Div Cardiol, Toronto, ON M5G 1X8, Canada
[3] Hosp Sick Children, Div Clin Biochem, Toronto, ON M5G 1X8, Canada
[4] Hosp Sick Children, Div Endocrinol, Toronto, ON M5G 1X8, Canada
[5] Toronto Gen Hosp, Div Nephrol, Toronto, ON, Canada
[6] Univ Toronto, Dept Biochem, Toronto, ON, Canada
[7] Univ Toronto, Dept Med, Toronto, ON, Canada
[8] Univ Toronto, Dept Immunol, Toronto, ON, Canada
[9] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada
关键词
vascular testing; cardiovascular risk factors; lipids; insulin resistance; LOW-DENSITY-LIPOPROTEIN; RISK-FACTORS; ACCELERATED ATHEROSCLEROSIS; MYOCARDIAL-PERFUSION; YOUNG-ADULTS; WOMEN; CHILDREN; DISEASE; HOMOCYSTEINE; PROGRESSION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To assess traditional and non-traditional cardiovascular risk factors and to determine the prevalence and correlates of early vascular markers of atherosclerosis in paediatric systemic lupus erythematosus (pSLE). Methods Fifty-four adolescents with pSLE had cardiovascular risk factor assessment, disease activity and vascular testing including carotid intima-media thickness (CIMT), flow-mediated dilatation (FMD), arterial stiffness measures, and myocardial perfusion studies. Results The traditional risk factors of hypertension, elevated triglycerides, apolipoprotein B, haemoglobin AI c and insulin levels and non-traditional risk factors of elevated homocysteine and fibrinogen were present (all p<0.001). Some arterial stiffness measures, central pulse wave velocity and characteristic impedance were elevated (p<0.001), but CIMT, FMD and myocardial perfusion were normal. Cumulative prednisone dose correlated with total cholesterol (r=0.5790, p<0.001) and elevated LDL-C (r=0.4488, p=0.0012). Hydroxychloroquine treatment correlated negatively with total cholesterol (r=-0.4867, p=0.0002), LDL-C (r=-0.4805, p=0.0002) and apolipoprotein B (r=-0.4443, p=0.0011). In multivariate analysis LDL-C correlated with cumulative prednisone dose and negatively with hydroxychloroquine treatment (R-2=0.40, p<0.001). Conclusions An increased burden of traditional and non-traditional risk factors and early evidence of insulin resistance and increased central arterial stiffness were present in paediatric SLE. Disease-specific and therapy-related factors are likely modifying these cardiovascular risk profiles warranting prospective longitudinal studies.
引用
收藏
页码:575 / 581
页数:7
相关论文
共 50 条
  • [1] Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus
    Roman, Mary J.
    Crow, Mary K.
    Lockshin, Michael D.
    Devereux, Richard B.
    Paget, Stephen A.
    Sammaritano, Lisa
    Levine, Daniel M.
    Davis, Adrienne
    Salmon, Jane E.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (10): : 3412 - 3419
  • [2] Rates and determinants of progression of atherosclerosis in systemic lupus erythematosus.
    Roman, Mary J.
    Lockshin, Michael D.
    Crow, Mary K.
    Paget, Stephen A.
    Devereux, Richard B.
    Sammaritano, Lisa
    Levine, Daniel M.
    Salmon, Jane E.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S521 - S521
  • [3] Atherosclerosis in Systemic Lupus Erythematosus
    Tobin, Rachel
    Patel, Nidhi
    Tobb, Kardie
    Weber, Brittany
    Mehta, Puja K.
    Isiadinso, Ijeoma
    CURRENT ATHEROSCLEROSIS REPORTS, 2023, 25 (11) : 819 - 827
  • [4] Atherosclerosis in systemic lupus erythematosus
    Croca, Sara
    Rahman, Anisur
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2017, 31 (03): : 364 - 372
  • [5] Atherosclerosis in Systemic Lupus Erythematosus
    Rachel Tobin
    Nidhi Patel
    Kardie Tobb
    Brittany Weber
    Puja K. Mehta
    Ijeoma Isiadinso
    Current Atherosclerosis Reports, 2023, 25 : 819 - 827
  • [6] Atherosclerosis in systemic lupus erythematosus
    Mezalek, Zoubida Tazi
    Harmouche, Hicham
    Ammouri, Wafaa
    Maamar, Mouna
    Adnaoui, Mohamed
    Cacoub, Patrice
    PRESSE MEDICALE, 2014, 43 (10): : 1034 - 1047
  • [7] Atherosclerosis in Systemic Lupus Erythematosus
    Stojan, George
    Petri, Michelle
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2013, 62 (03) : 255 - 262
  • [8] Atherosclerosis in systemic lupus erythematosus
    Sherer, Yaniv
    Zinger, Hasia
    Shoenfeld, Yehuda
    AUTOIMMUNITY, 2010, 43 (01) : 98 - 102
  • [9] Atherosclerosis and systemic lupus erythematosus
    Urowitz M.
    Gladman D.
    Bruce I.
    Current Rheumatology Reports, 2000, 2 (1) : 19 - 23
  • [10] Atherosclerosis in systemic lupus erythematosus
    Salmon, JE
    Lockshin, MD
    Paget, SA
    Devereux, RB
    Crow, MK
    Roman, MJ
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 13 - 13